Report: Dementia Treatment Prevalence and Related Costs Have Increased 31% in Last Decade

November 16, 2022 | Strategic Insights for Health System

Preview

​What**'**s**the**news. Treatment prevalence and related costs for Alzheimer's disease and related dementias (ADRD) have increased to $2.43 million—a 31% increase over the last decade, according to a November 2022 Milken Institute report.

Access Full Content

Contact us today at 610.825.6000.